MarketInOut Stock Screener Log In | Sign Up
 

Bayer AG

XETRA • Healthcare • Drug Manufacturers - General • Quote as of 06/19/2026 15:55
Bayer AG stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization36,497 mln
Float982 mln
Earnings Date08/04/2026

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.78
Likely reliable

1-Year Forecast

49.50
Strong upside

Relative Strength

78 / 100
Strongly outperforming

Debt / Equity

1.26
Elevated leverage

Pre-Tax Margin

16%
Healthy margin

Business Description

Founded in 1863 and headquartered in Leverkusen, Germany, Bayer is a global life sciences company serving customers across Europe, North America, Asia Pacific, Latin America, and beyond. Its healthcare business spans prescription medicines for heart conditions, women's health, cancer, and eye disease, alongside everyday over-the-counter products such as pain relievers, allergy treatments, and nutritional supplements. Through its agriculture division, Bayer supplies farmers with crop protection products, seeds, and digital tools designed to improve yields and manage pests and weeds. The company sells through pharmacies, supermarkets, hospitals, and online retailers, as well as directly to those working in farming.

Key Fundamentals

EPS-2.19
ROE-7.32
RPS46.05
ROIC7.69
ROA-2.03
Interest Cover3.58
EBITDA, mln2,946
EV / EBITDA22.45
EV / EBIT817
Revenue, mln45,242
EV / Revenue1.47

Financial Strength

Altman Z-Score0.73
Piotroski F-Score 7 / 9
Beneish M-Score-2.78
Price to Intrinsic Value0.74
1-Year Target Price49.50
Shiller PE Ratio41.77

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.43% 83 / 100   
1 Month -3.8% 15 / 100   
2 Months -4.07% 15 / 100   
6 Months 4.17% 42 / 100   
1 Year 40.66% 83 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us